0001654954-23-001909.txt : 20230221 0001654954-23-001909.hdr.sgml : 20230221 20230221105611 ACCESSION NUMBER: 0001654954-23-001909 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230221 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SMITH & NEPHEW PLC CENTRAL INDEX KEY: 0000845982 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14978 FILM NUMBER: 23646040 BUSINESS ADDRESS: STREET 1: BUILDING 5, CROXLEY PARK STREET 2: HATTERS LANE CITY: WATFORD, HERTFORDSHIRE STATE: X0 ZIP: WD18 8YE BUSINESS PHONE: 44 (0) 1923 477 100 MAIL ADDRESS: STREET 1: BUILDING 5, CROXLEY PARK STREET 2: HATTERS LANE CITY: WATFORD, HERTFORDSHIRE STATE: X0 ZIP: WD18 8YE 6-K 1 a6065q.htm DIRECTOR/PDMR SHAREHOLDING a6065q
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
Report of Foreign Private Issuer
 
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
 
February 21, 2023
 
Commission File Number 001-14978
 
SMITH & NEPHEW plc
(Registrant's name)
 
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
 
(Address of registrant's principal executive offices)
 
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
 
Form 20-F X                Form 40-F
    ---                               ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
 
Yes                        No X
---                         ---
 
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
 
Yes                      No X
---                         ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
 
Yes                  No X
---                   ---
 
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
 
 
 
 
Director/PDMR Shareholding
 
SMITH & NEPHEW PLC
 
21 February 2023
 
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.
 
Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.
 
Smith & Nephew Global Share Plan 2020 (Performance Share Awards):
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Smith & Nephew plc
LEI
213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code
ISIN: GB0009223206
Nature of the transaction
Lapse of Performance Share Awards granted on 21 May 2020 under the Smith & Nephew Global Share Plan 2020
Date of Transaction
2023 - 02 - 21
Place of Transaction
Lapse took place outside a trading venue
 
 
Number of ordinary shares under award granted on 21/05/2020 (shown at maximum)
 
Number of ordinary shares lapsed under award (shown at maximum)
 
Number of ordinary shares outstanding under award (shown at maximum)
 
Helen Barraclough
(Group General Counsel & Company Secretary)
 
10,982
 
10,982
 
0
 
Bradley Cannon
(President Orthopaedics, Sports Medicine & ENT and Americas)
 
29,624
 
29,624
 
0
 
Phil Cowdy
(Chief Corporate Development & Corporate Affairs Officer)
 
19,860
 
19,860
 
0
 
Myra Eskes
(President APAC Region & Global Service)
 
29,392
 
29,392
 
0
 
Simon Fraser
(President Advanced Wound Management & Global Commercial Operations)
 
25,628
 
25,628
 
0
 
Elga Lohler
(Chief HR Officer)
 
26,472
 
26,472
 
0
 
Vasant Padmanabhan
(President Research & Development)
 
25,638
 
25,638
 
0
 
 
Notes:
 
(i)      Following completion of the performance measurement period, these awards lapsed in full on 21 February 2023.
 
(ii)     Details regarding the performance against targets as set at the grant date will be disclosed within the Annual Report which is to be published on 6 March 2023.
 
This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.
 
Sarah Carne  
Deputy Company Secretary
Smith & Nephew plc
Tel:      +44 (0) 1923 477100
 
 
 
 
 
 
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Smith & Nephew Plc
(Registrant)
 
 
Date: February 21, 2023
 
 
By: /s/ Helen Barraclough
-----------------
                                                                                                                              Helen Barraclough
                                                                                                                      Company Secretary